COMPOUND USED AS BCR-ABL INHIBITOR - CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD

Title:

COMPOUND USED AS BCR-ABL INHIBITOR

Document Type and Number:

WIPO Patent Application WO/2022/247919

Kind Code:

A1

Abstract:

Provided are a compound used as a BCR-ABL inhibitor, namely a compound of formula (I), or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition comprising the compound. Moreover, the present invention relates to a use of the compound in the preparation of a drug for treating BCR-ABL related diseases.

More Like This:

WO/2012/073254	A PROCESS FOR THE PREPARATION OF PAZOPANIB USING NOVEL INTERMEDIATE
WO/2003/040103	$g(b)-SULFONE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
WO/2007/106721	CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING OBESITY

Inventors:

ZHANG YINSHENG (CN)
LIU XIN (CN)
QIN HUI (CN)
YE JIAWEI (CN)
WANG JINAN (CN)
WU SONGSONG (CN)

Application Number:

PCT/CN2022/095436

Publication Date:

December 01, 2022

Filing Date:

May 27, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)

International Classes:

C07D403/02; A61K31/41; A61K31/435; A61P35/00; C07D401/02; C07D401/14; C07D403/14; C07D405/02; C07D405/14; C07D413/02; C07D413/14; C07D487/02

Domestic Patent References:

WO2021143927A1	2021-07-22
WO2018133826A1	2018-07-26
WO2013171639A1	2013-11-21

Foreign References:

CN104334529A	2015-02-04
CN104379574A	2015-02-25
CN104302638A	2015-01-21
CN109651359A	2019-04-19
CN104302634A	2015-01-21

Other References:

ANDREW A. WYLIE ET AL., NATURE, vol. 543, 2017, pages 733 - 737
"Greene's Protective Groups in Organic Synthesis", JOHN WILEY & SONS, INC

Attorney, Agent or Firm:

BEIJING SUNHOPE INTELLECTUAL PROPERTY LTD. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHODS FOR TRANSMITTING AND RECEIVING DATA, RESOURCE INDICATION METHOD AND APPARATUS, AND SYSTEM

Next Patent: QUINOLINAMINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS